• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性腹水型腹膜间皮瘤的延迟诊断:一例报告

Delayed Diagnosis of Peritoneal Mesothelioma in Recurrent Ascites: A Case Report.

作者信息

Javed Hafiz, Ahmad Arfa, Rehman Abdul, Wagner Michael, McKnight John E

机构信息

Department of Medicine, TidalHealth Peninsula Regional, Salisbury, MD, USA.

Department of Pathology, TidalHealth Peninsula Regional, Salisbury, MD, USA.

出版信息

Am J Case Rep. 2025 Apr 6;26:e946777. doi: 10.12659/AJCR.946777.

DOI:10.12659/AJCR.946777
PMID:40188356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11991405/
Abstract

BACKGROUND Ascites is a common clinical sign noted in 3% to 4% of hospitalized medical patients. Nearly 94% of patients with ascites have non-malignant etiologies, with the most common being chronic liver disease. Peritoneal mesothelioma is an exceedingly rare malignancy associated with asbestos exposure. Here, we report the case of an elderly man who presented with recurrent loculated ascites and received a diagnosis of peritoneal mesothelioma after a delay of approximately 10 weeks. CASE REPORT A 67-year-old man with a history of asbestos exposure presented with abdominal distension and muscle wasting for 1 month. Initial abdominal CT was notable for smooth liver contour and massive ascites. Ascitic fluid analysis was consistent with low serum albumin-ascites gradient but showed negative cytology for malignant cells. Upper and lower endoscopies did not reveal lesions. Due to recurring ascites, serial abdominal paracenteses were performed, although cytology was negative for malignant cells. Repeat abdominal CT performed after 6 weeks showed worsening loculated ascites, with possible peritoneal carcinomatosis. At this point, percutaneous omental biopsy was performed, which established the diagnosis of peritoneal mesothelioma (75 days after initial presentation). CONCLUSIONS In patients presenting with recurrent ascites and a history of asbestos exposure, it is important to consider the diagnosis of peritoneal mesothelioma. While 94% of patients with ascites have non-malignant etiologies, a small proportion of patients can have malignant ascites. In patients in which the first set of ascitic fluid studies are inconclusive, repeat abdominal paracentesis and omental biopsy or diagnostic laparoscopy should be expedited to avoid delays in diagnosis.

摘要

背景

腹水是住院内科患者中常见的临床体征,在3%至4%的患者中可见。近94%的腹水患者病因非恶性,最常见的是慢性肝病。腹膜间皮瘤是一种与石棉暴露相关的极其罕见的恶性肿瘤。在此,我们报告一例老年男性患者,其表现为复发性局限性腹水,在延迟约10周后被诊断为腹膜间皮瘤。

病例报告

一名有石棉暴露史的67岁男性,出现腹胀和肌肉萎缩1个月。初始腹部CT显示肝脏轮廓光滑,有大量腹水。腹水分析与低血清白蛋白-腹水梯度一致,但恶性细胞细胞学检查为阴性。上消化道和下消化道内镜检查未发现病变。由于腹水反复出现,进行了多次腹腔穿刺术,尽管恶性细胞细胞学检查为阴性。6周后重复腹部CT显示局限性腹水恶化,可能存在腹膜癌转移。此时,进行了经皮大网膜活检,确诊为腹膜间皮瘤(初次就诊75天后)。

结论

对于出现复发性腹水且有石棉暴露史的患者,考虑腹膜间皮瘤的诊断很重要。虽然94%的腹水患者病因非恶性,但一小部分患者可能有恶性腹水。对于初次腹水检查结果不明确的患者,应加快重复腹腔穿刺术和大网膜活检或诊断性腹腔镜检查,以避免诊断延误。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/d9fe59900bd5/amjcaserep-26-e946777-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/0b5620c2e1ba/amjcaserep-26-e946777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/b067f90fdc7a/amjcaserep-26-e946777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/a09f3f810495/amjcaserep-26-e946777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/d9fe59900bd5/amjcaserep-26-e946777-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/0b5620c2e1ba/amjcaserep-26-e946777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/b067f90fdc7a/amjcaserep-26-e946777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/a09f3f810495/amjcaserep-26-e946777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c916/11991405/d9fe59900bd5/amjcaserep-26-e946777-g004.jpg

相似文献

1
Delayed Diagnosis of Peritoneal Mesothelioma in Recurrent Ascites: A Case Report.复发性腹水型腹膜间皮瘤的延迟诊断:一例报告
Am J Case Rep. 2025 Apr 6;26:e946777. doi: 10.12659/AJCR.946777.
2
A Rare Case of Biphasic Malignant Peritoneal Mesothelioma with Refractory Ascites.一例罕见的伴有难治性腹水的双相性恶性腹膜间皮瘤病例。
Intern Med. 2017;56(7):861-864. doi: 10.2169/internalmedicine.56.7791. Epub 2017 Apr 1.
3
Education and imaging. Gastrointestinal: indolent case of malignant peritoneal mesothelioma with massive ascites.教育与影像学。胃肠道:伴有大量腹水的惰性恶性腹膜间皮瘤病例。
J Gastroenterol Hepatol. 2014 Apr;29(4):662. doi: 10.1111/jgh.12535.
4
Diffuse malignant peritoneal mesothelioma.弥漫性恶性腹膜间皮瘤。
Kaohsiung J Med Sci. 2013 Nov;29(11):642-5. doi: 10.1016/j.kjms.2013.05.003. Epub 2013 Aug 12.
5
[A case of peritoneal mesothelioma without a history of asbestos exposure].[一例无石棉接触史的腹膜间皮瘤病例]
Korean J Gastroenterol. 2006 Mar;47(3):224-8.
6
Peritoneal malignant mesothelioma: Slippery like an eel to diagnose on cytology-case series of 3 cases.腹膜恶性间皮瘤:在细胞学检查中如鳗鱼般难以诊断——3例病例系列报道
J Am Soc Cytopathol. 2022 Jan-Feb;11(1):40-45. doi: 10.1016/j.jasc.2021.08.007. Epub 2021 Sep 9.
7
[Recurrent ascites in peritoneal mesothelioma. Its diagnostic and therapeutic management].[腹膜间皮瘤中的复发性腹水。其诊断与治疗管理]
Rev Esp Enferm Dig. 1995 Mar;87(3):263-6.
8
Malignant peritoneal mesothelioma.恶性腹膜间皮瘤
Tumori. 2005 Jan-Feb;91(1):1-5. doi: 10.1177/030089160509100101.
9
Malignant peritoneal mesothelioma.恶性腹膜间皮瘤
Am J Med Sci. 2023 Jan;365(1):99-103. doi: 10.1016/j.amjms.2022.07.008. Epub 2022 Aug 6.
10
Metastatic peritoneal mesothelioma in the setting of recurrent ascites: a case report.复发性腹水背景下的转移性腹膜间皮瘤:一例报告
Diagn Cytopathol. 2010 Sep;38(9):675-81. doi: 10.1002/dc.21300.

本文引用的文献

1
Incidental Diagnosis of Malignant Peritoneal Mesothelioma During Liver Transplantation Surgery: A Case Report.肝移植手术中偶然诊断出恶性腹膜间皮瘤:一例报告
Am J Case Rep. 2024 Jul 17;25:e943787. doi: 10.12659/AJCR.943787.
2
Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990-2019.全球 204 个国家和地区归因于职业性石棉暴露的间皮瘤全球负担:1990-2019 年。
J Cancer Res Clin Oncol. 2024 May 28;150(5):282. doi: 10.1007/s00432-024-05802-6.
3
Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.
恶性腹膜间皮瘤治疗策略与结局分析:一项多中心研究的见解
Ann Surg Oncol. 2024 Sep;31(9):6228-6236. doi: 10.1245/s10434-024-15506-3. Epub 2024 May 28.
4
Rapid Progression of Malignant Peritoneal Mesothelioma Mimicking a Postoperative Complication in a Young Woman: A Case Report.恶性腹膜间皮瘤快速进展,酷似年轻女性术后并发症:病例报告。
Am J Case Rep. 2024 May 28;25:e942948. doi: 10.12659/AJCR.942948.
5
Narrative review of malignant ascites: epidemiology, pathophysiology, assessment, and treatment.恶性腹水的叙述性综述:流行病学、病理生理学、评估和治疗。
Ann Palliat Med. 2024 Jul;13(4):842-857. doi: 10.21037/apm-23-554. Epub 2024 Apr 18.
6
Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.目前临床实践中腹膜间皮瘤的基因组特征分析及潜在治疗靶点的检测。
Clin Exp Med. 2024 Apr 20;24(1):80. doi: 10.1007/s10238-024-01342-y.
7
Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group.间皮瘤病理诊断指南:国际间皮瘤兴趣小组共识声明的 2023 年更新。
Arch Pathol Lab Med. 2024 Nov 1;148(11):1251-1271. doi: 10.5858/arpa.2023-0304-RA.
8
Differential diagnosis of ascites: etiologies, ascitic fluid analysis, diagnostic algorithm.腹水的鉴别诊断:病因、腹水分析、诊断算法
Clin Chem Lab Med. 2023 Dec 20;62(7):1266-1276. doi: 10.1515/cclm-2023-1112. Print 2024 Jun 25.
9
A 51-Year-Old Woman with Advanced Peritoneal Mesothelioma and Stage 3b Chronic Kidney Disease Treated with Cytoreductive Surgery and Bidirectional Intraperitoneal Cisplatin and Ifosfamide Chemotherapy: A Case Report.一名 51 岁女性患有晚期腹膜间皮瘤和 3b 期慢性肾脏病,接受细胞减灭术和顺铂与异环磷酰胺双向腹腔内化疗治疗:病例报告。
Am J Case Rep. 2023 Dec 14;24:e941726. doi: 10.12659/AJCR.941726.
10
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature.腹膜间皮瘤原位:三例报告及文献复习。
Histopathology. 2024 Feb;84(3):492-506. doi: 10.1111/his.15092. Epub 2023 Dec 12.